The AHA has published a scientific statement regarding cardiovascular toxicity in patients with history of treatment for childhood cancer.

Developing a new regimen is urgently needed. This phase I study evaluated the maximum tolerated dose (MTD), safety, and efficacy of mitoxantrone hydrochloride liposome (Lipo-MIT) plus cyclophosphamide ...

Novel biomarkers, such as dysfunctional miRNAs (e.g., miRNA-34a), are closely linked to anthracycline-treated patients. Additionally, human induced pluripotent stem cell-derived cardiomyocytes ...

HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug ...

Certain chemotherapy agents, particularly anthracyclines (like doxorubicin) and targeted therapies (such as trastuzumab), are known to cause direct damage to cardiac tissues. - Anthracyclines: These ...